Promega developing OncoMate MSI assay as companion diagnostic for endometrial cancer drug candidate from Incyte
Promega developing OncoMate MSI assay as companion diagnostic for endometrial cancer drug candidate from Incyte. (Credit: Belova59 from Pixabay)